静脉血栓栓塞的非抗凝剂策略 预防 预防 静脉血栓塞的预防
Gerard Gurumurthy1, Jecko Thachil2
1The Queen Elizabeth Hospital King's Lynn NHS Foundation Trust, King's Lynn, United Kingdom.
Seminars in thrombosis and hemostasis
|October 15, 2025
概括
像阿司匹林和他类非抗凝药物在预防静脉血栓塞栓症 (VTE) 方面表现有前途,而不会增加出血风险. 需要进一步的研究来证实这些以及其他新兴的VTE预防策略的有效性和安全性.
科学领域:
- 心脏病学 心脏病学
- 血液学 血液学 血液学
- 药理学 药理学是指药理学的学科.
背景情况:
- 静脉血栓塞栓症 (VTE) 是可预防的发病率和死亡率的重要原因.
- 目前对VTE的抗凝血预防受到出血风险和禁忌的限制.
- 越来越多的人对预防VTE的非抗凝剂策略感兴趣.
研究的目的:
- 审查VTE预防中的替代或辅助非抗凝剂策略的证据.
- 评估各种药物类别在减轻血栓形成风险而不增加出血并发症方面的疗效和安全性.
主要方法:
- 对用于预防VTE的非抗凝剂现有研究和临床试验的审查.
- 从随机对照试验和观察性研究中分析数据.
- 评估新兴药物类别,包括阿司匹林,他类药物,甲胺,GLP-1RA,PCSK9抑制剂,SGLT2抑制剂和RAAS调节剂.
主要成果:
- 阿司匹林在静脉瘤预防方面表现出有效性,特别是在骨科患者群体中,具有有利的安全性.
- 已经证明,他类药物可以减少静脉瘤发病率,而不会增加出血.
- 甲胺显示出降低静脉瘤风险的潜力,但缺乏随机数据.
- 葡萄糖样1受体激动剂 (GLP-1 RAs) 显示出潜在的但不一致的发现.
- 其他药物,如PCSK9抑制剂,SGLT2抑制剂和RAAS调节剂,对VTE预防有混合或有限的证据.
结论:
- 几种非抗凝剂,包括阿司匹林和他类药物,显示出作为VTE预防的替代品或辅助剂的希望.
- 关于最佳患者选择,使用时间和组合治疗,仍然存在重大不确定性.
- 进一步的随机试验至关重要,以确定这些药物的疗效,安全性和VTE预防的指导位置.
相关概念视频
01:29Venous Thrombosis III: Interprofessional Care
280
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
280
01:30Venous Thrombosis IV: Nursing Management
196
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
196
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.7K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.7K
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.1K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.1K
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
289
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
289
01:27Pulmonary Embolism III: Nursing Management
356
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
356